Allowable costs
- Data collection and analysis
- Research lab supplies and assays
- Study staff, students, post-docs, and project personnel
- Research travel and travel for the next proposal
Technology-enabled pilot funding for regional diabetes translation research focused on equity, feasibility, and future extramural support at GCDTR's Southeastern partner institutions.
01Regional Technologies Advancing Translation and Equity Core
The program supports exploratory, feasibility, and formative studies that identify gaps in technological capabilities and barriers to equitable adoption of diabetes technologies. Funding generates preliminary data for a subsequent NIDDK or other external application. Projects should align with T2–T4 translation research on diabetes, its complications, prediabetes or metabolic syndrome, or obesity.
02Budget and submission
Budgets use the NIH R&R detailed format with no indirect costs.
03Illustrative topic areas
04Regional network
05How to apply
Submit a single-PDF letter of intent, then a full application by the receipt date.
Single PDF due April 25, 2025.
Receipt date November 1, 2025.
Anticipated start date January 1, 2026.